AI Science Tracker
EN

Blood Transcript Biomarkers Selected by Machine Learning Algorithm Classify Neurodegenerative Diseases including Alzheimer's Disease

ASU-Banner Neurodegenerative Disease Research Center, Arizona State University, Tempe, Arizona, USA · 29 Oct 2022 · medicine

Discovery

Blood Transcript Biomarkers Selected by Machine Learning Algorithm Classify Neurodegenerative Diseases including Alzheimer's Disease

Source check: Source checked. Not independent scientific confirmation.

Finding: Across eight cohorts, results support exploratory disease/control discrimination, with variable performance by disease and cohort. Cross-cohort preprocessing and heterogeneous results limit interpretation; the panels are not established clinical diagnostics.

Technology: Random-forest feature selection and linear discriminant analysis evaluate blood-transcript panels across six neurodegenerative diseases.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Random-forest feature selection and linear discriminant analysis evaluate blood-transcript panels across six neurodegenerative diseases.
Test and result
Across eight cohorts, results support exploratory disease/control discrimination, with variable performance by disease and cohort.
Limitation / still unknown
Cross-cohort preprocessing and heterogeneous results limit interpretation; the panels are not established clinical diagnostics.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC9687215/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.